Dr. Mehmet Oz made it plain on The Record with Greta Van Susteren that the Trump administration is finally taking the fight to Big Pharma and putting working Americans ahead of corporate profits. Oz praised President Trump’s executive order as a powerful step toward fairer drug pricing that stops families from choosing between groceries and medicine.
The May 12, 2025 executive order that Oz celebrated is being sold as a common-sense rebalancing — not price controls, but leverage and accountability after decades of double standards. Conservatives should cheer any policy that restores fairness without crushing innovation, and Oz argued the move creates a smarter, more patient-centered system.
This administration pushed farther still, negotiating real price concessions from manufacturers and announcing major deals designed to bring down the sticker shock on GLP-1 weight-loss drugs while expanding access for Medicare beneficiaries. The new agreements promise lower monthly prices and caps for seniors, a direct result of pressure and negotiation rather than empty promises.
Make no mistake: the road has not been smooth or linear — the administration previously pushed back on a Biden-era regulatory proposal to have Medicare directly pick up the tab for obesity drugs, a fiscally cautious move that critics misread as indifference. Conservatives understand the need to be responsible with taxpayer dollars while still forcing industry to stop gouging Americans.
Dr. Oz has been blunt about the power imbalance that allowed pharmaceutical giants to keep prices sky-high until someone in Washington refused to look the other way, and he’s celebrated the moment when industry finally faced consequences. Big Pharma doesn’t like having their playbook exposed, which is exactly why the president’s pressure has been effective — these companies had to choose between fair play and losing public trust.
Beyond politics, this fight is about outcomes: lower out-of-pocket costs mean people take their meds, chronic conditions are managed, and taxpayers ultimately pay less for emergency care and complications. That argument is rooted in common-sense economics — spending a little now to prevent vastly greater costs later — and it’s exactly the conservative approach to responsible governance.
Hardworking Americans deserve leaders who will stand up to corporate power and deliver results, not endless committee hearings and press releases. If the administration keeps pressing for accountability, transparency, and better prices, conservatives should rally behind those policies and refuse to let the swamp and its lobbyists dictate the terms of our care.

